[HTML][HTML] Drug repurposing for the treatment of bacterial and fungal infections

A Miró-Canturri, R Ayerbe-Algaba… - Frontiers in microbiology, 2019 - frontiersin.org
Multidrug-resistant (MDR) pathogens pose a well-recognized global health threat that
demands effective solutions; the situation is deemed a global priority by the World Health …

New horizons for old drugs and drug leads

GM Cragg, PG Grothaus… - Journal of natural products, 2014 - ACS Publications
There is mounting urgency to find new drugs for the treatment of serious infectious diseases
and cancer that are rapidly developing resistance to previously effective drugs. One …

Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen

M Xu, EM Lee, Z Wen, Y Cheng, WK Huang, X Qian… - Nature medicine, 2016 - nature.com
In response to the current global health emergency posed by the Zika virus (ZIKV) outbreak
and its link to microcephaly and other neurological conditions, we performed a drug …

[HTML][HTML] Early state research on antifungal natural products

M Negri, TP Salci, CS Shinobu-Mesquita, IRG Capoci… - Molecules, 2014 - mdpi.com
Nosocomial infections caused by fungi have increased greatly in recent years, mainly due to
the rising number of immunocompromised patients. However, the available antifungal …

[HTML][HTML] Emerging therapies targeting the ubiquitin proteasome system in cancer

NM Weathington, RK Mallampalli - The Journal of clinical …, 2014 - Am Soc Clin Investig
The ubiquitin proteasome system (UPS) is an essential metabolic constituent of cellular
physiology that tightly regulates cellular protein concentrations with specificity and precision …

[HTML][HTML] Antifungal drug repurposing

JH Kim, LW Cheng, KL Chan, CC Tam, N Mahoney… - Antibiotics, 2020 - mdpi.com
Control of fungal pathogens is increasingly problematic due to the limited number of
effective drugs available for antifungal therapy. Conventional antifungal drugs could also …

Antifungal resistance, metabolic routes as drug targets, and new antifungal agents: an overview about endemic dimorphic fungi

JA Parente-Rocha, AM Bailão… - Mediators of …, 2017 - Wiley Online Library
Diseases caused by fungi can occur in healthy people, but immunocompromised patients
are the major risk group for invasive fungal infections. Cases of fungal resistance and the …

Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria

W Sun, RA Weingarten, M Xu, N Southall… - Emerging microbes & …, 2016 - Taylor & Francis
Current antimicrobial susceptibility testing has limited screening capability for identifying
empirical antibiotic combinations to treat severe bacterial infections with multidrug-resistant …

The NCATS Pharmaceutical Collection: a 10-year update

R Huang, H Zhu, P Shinn, D Ngan, L Ye, A Thakur… - Drug Discovery …, 2019 - Elsevier
Highlights⿢NPC repurposing screens discovered compounds with new clinical
indications.⿢Systematic NPC screening data establishes rich drug activity …

An update on the global treatment of invasive fungal infections

ME Munzen, AD Goncalves Garcia… - Future …, 2023 - Taylor & Francis
Fungal infections are a serious problem affecting many people worldwide, creating critical
economic and medical consequences. Fungi are ubiquitous and can cause invasive …